JUNS

NASDAQ · Pharmaceuticals

Jupiter Neurosciences Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.24

-0.01 (-4.74%)

JUNS News1 articles

Jupiter Neurosciences Shares Plunge on $100M MDMA Deal and Dilutive Offering

Jupiter Neurosciences shares fell 37% to $0.205 after announcing a $100M licensing deal for MDMA drug ALA-002 and a $2M stock offering, with trading volume exceeding 230 million shares.